Dawei Xuan, PhD
About Dawei Xuan, PhD
Dawei Xuan, Ph.D., is the Senior Vice President of Clinical Pharmacology, known for his contributions to the development of three marketed medicines and his extensive experience in the pharmaceutical industry.
Dawei Xuan, Ph.D. - Senior Vice President of Clinical Pharmacology
Dawei Xuan, Ph.D., currently holds the title of Senior Vice President of Clinical Pharmacology. With an extensive background in the pharmaceutical industry, he has held pivotal roles that contribute significantly to his area of expertise. His experience spans over two decades, covering various critical positions that demonstrate his leadership in clinical pharmacology.
Dawei Xuan Education and Expertise
Dawei Xuan earned a Ph.D. in pharmaceutical sciences from the University of Connecticut, adding to his foundational B.S. in pharmaceutical sciences obtained from Peking University Health Science Center. His academic credentials have equipped him with a deep understanding of pharmaceutical sciences, making him an expert in clinical pharmacology. His expertise is further honed by significant contributions to the field, including the discovery and development of several marketed medicines.
Dawei Xuan Background at TPTX and Pfizer
Before his current role, Dawei Xuan served as Vice President of Clinical Pharmacology at Turning Point Therapeutics (TPTX). His career at Pfizer spanned 17 years, culminating as Senior Director of Clinical Pharmacology in the Early Oncology Development and Clinical Research organization. During his tenure at Pfizer, he played a crucial role in the development of key pharmaceuticals, showcasing his in-depth knowledge and practical experience in the field.
Dawei Xuan's Contributions to Pharmaceutical Development
Dawei Xuan has contributed to the discovery and development of three marketed medicines: Eliquis, Inspra, and Ibrance. His work in these areas highlights his proficiency in clinical pharmacology and his significant impact on drug development. These contributions reflect his ability to apply his academic knowledge to practical and impactful pharmaceutical advancements.
Dawei Xuan's Early Career at Center for Anti-infective Research and Development
Earlier in his career, Dawei Xuan spent nine years working in clinical pharmacokinetics and pharmacodynamics of antimicrobial agents at the Center for Anti-infective Research and Development at Hartford Hospital. This early experience laid the foundation for his future achievements in clinical pharmacology and demonstrates his longstanding commitment to pharmaceutical research and development.